IL1B and Alzheimer disease: Additionally, Western blot and IF analyses demonstrated that XSB treatment significantly reduced TNF-α and IL-1β protein levels (Figure 8) while increasing BDNF, SYN, and PSD95 expression in the hippocampus of AD model mice (Figure 9).